Building healthy lives through genomics
Order online to your doorstep
Find the right test
How's the test done?
Contents include 1 sample collection kit intended for collection and stabilization of DNA from human oral samples.
How's the test done?
Place the soft cotton end inside your cheek and swipe the left and right side ten times each.
How's the test done?
Twist the top end of the sample collector and place the soft cotton end inside the cylinder along with the blue liquid
How's the test done?
To complete the process, shake the sample collector fifteen times vigorously
Why Genomepatri ™?
Genomepatri ™ is a revolutionary test that gives you an insight into your genomics predisposition and provides a road map for your wellness.
Our team of expert genomics counselors have your best interests at heart and work towards helping you achieve your wellness potential by providing you with strong insights and healthy practices for your future.
Secretary, Information Technology (IT); Government of Telangana
I am very impressed by the depth of the report and also the balanced way it has been presented.
Director, Global Solutions and Innovation, Hitachi Consulting
Genomapatri is a must for everyone. It reveals great amount of details about the self as well the possible risk levels for multiple health condi...
Digital Transformation, Chief Digital Officer, Blockchain, Entrepreneur, CEO; TAS, MSFT, Mahindra; Startups, Speaker, Writer
I have been fascinated by the whole science of genomics, and how it can be used to predict what kind of diseases, etc. one i...
Member of Parliament, India, and Chairman of the Parliamentary Committee for External Affairs
Dear Anu, thank YOU! I found the report hugely impressive, remarkably accurate about my overall health and very professionally and helpfully done. I would ...
Managing Director, Head of India and Asia Pacific at General Atlantic
Thank you Anu for the GenomePatri. The service was brilliant, handling was professional and the insights very helpful. The depth and detail of...
Latest from blog
Going Gluten-Free? Few Points to Remember
Research in the past has reported that more than 30% of the patients have deficiencies to dietary fiber, proteins and minerals coupled with imperfect absorption of iron, folic acid and calcium. This deficiency can be overcome by consuming gluten free foods and processed gluten free products which contain good sources of lipids, sugars and fats. Continue Reading →
Lactose Intolerance – Dietary Management
Till date, there’s no “gold standard” test for assessing Lactose Intolerance (LI). However, at Mapmygenome, through our proprietary test MyNutriGene, you can get an insight into the weaknesses of your immunity, genetic predisposition to specific health conditions, and helps in pre-empting most of these risks. Continue Reading →
Cholesterol: The Good, The Bad (And The Ugly?)
Although it is not feasible to prevent causes that lead to the advancement of atherosclerosis, a few of them like low cancer incidence can be controlled by taking food products rich in whole-wheat bread, fruits, nuts and vegetables. Other preferred dietary products are omega-3 fatty acids and phenol compounds like apples, citrus fruits, berries, and mangoes etc. Continue Reading →
2018 W-Power Trailblazers:
Anu Acharya hopes to save a million lives by decoding genetic makeup
Mapmygenome allows "healthy people to stay healthy" by decoding their genetic makeup
CEO, Mapmygenome India
If the complex world of genes befuddles you, turn to Anu Acharya, CEO of Mapmygenome India, a personal genomics company. As Acharya would cut the jargon and tell you, her company “allows healthy people to stay healthy” by decoding their genetic makeup and guides them on “how to become healthier”. By 2030, she expects to touch a 100 million lives and save a million.
Mapmygenome is Acharya’s second startup in the field of genetics. In 2000, she started Ocimum Biosolutions, a genomic services company. While Ocimum is still run by its other founders, Acharya has moved beyond laboratory information management systems and pure informatics to delve into the world of personal genomics. She launched Mapmygenome in 2013. Today, the Hyderabad-based company is also building a database of associations between gene mutations and traits or conditions specific to the Indian population to advance personalised medicine in the country.
The company has processed more than 10,000 samples so far through ‘Genomepatri’ (a take-off on janampatri, or horoscope), a simple, saliva-based test to decode DNA and predict genetic risk for 100-plus diseases, traits, drug responses and carrier statuses. “While it is a product, it is ultimately delivered as a service,” says Acharya, who holds a graduate degree from IIT-Kharagpur, and postgraduate degrees in physics and management information systems from the University of Illinois. Apart from a comprehensive, analytical report, customers can also get consultations by certified genetic counsellors who prescribe lifestyle changes, and services such as nutritional meal plans and food delivery (currently only in Hyderabad).
Acharya recalls the initial challenges of fundraising, given that she was “in an area that is difficult for people to understand”. “If you are a woman founder, there is a reservation against that also,” she adds. But the company managed to rise on the back of a $1.1 million pre-series A funding, and founder investment of around $2 million in 2016. Some of its prominent investors include Rajan Anandan, vice president, Southeast Asia and India, and managing director of Google India, and Ratan Tata. Mapmygenome has clocked a compound annual growth rate of 84 percent for the past 3 years. It will end the year with ₹6 crore in revenues and negative Ebitda.
“Anu is a smart serial entrepreneur who has been a pioneer in India in BioIT and in personal and recreational genetics sectors in India. Her prowess in digital marketing and use of social networks has been evident in the foray with Mapmygenome,” says Vijay Chandru, chairman & managing director, Strand Life Sciences.
Her last year’s highlights include developing Medicamap, a genetic test popular among doctors for its ability to analyse response and sensitivity to 100-plus drugs. In terms of strategic partnerships, its new clients include institutions such as Gopichand Academy, Reliance Jio, GOQii, CallHealth and 1mg.
“The main thing was finally we’ve been able to get to (the point) where almost everybody is interested in getting a genetic test done. That is the big change for our business,” says Acharya.
Janampatri or Genomepatri Mapmygenome is moving fast in the genetics and diagnostics space to build a map of the Indian genome
Matt Ridley, the author of the book ‘Genome: The Autobiography of a Species in 23 chapters’, says that the genome is a book that wrote itself, continually adding, deleting and amending over four billion years. The human genome and genetic makeup have always been a topic for research and scientists.
Anu Acharya started Mapmygenome in 2011 to ensure that people are aware of their genetic makeup and work towards preventing diseases. “Genetics has always been a fascinating subject. However, India doesn’t have the same access as the west. If you look at the amount of data available on the Indian genome it is limited. Even if one out of every six individuals are Indian, we are not there in terms of understanding our own genetic makeup,” says Anu.
The uphill task
After two years of hard work and efforts, Anu and her team got in all the data on the Indian genes and genetic makeup and decided to the build it as a test for consumers. It was the beginning of the Genomepatri.
Today, Mapmygenome and its famous Genomepatri doesn’t need any introduction. The ride, nevertheless, hasn’t been all easy. Over the past two and half years, the team has also realised that preventive cure in India still has a very long way to go. Anu adds that this could be because of the ‘we’ll cross the bridge when we get there’ attitude.
“Today, there are approximately 332 million diabetic patients in the world and out of these 62 million come from India. But most people refuse to see this as a problem. I have relatives who have high sugar levels, but don’t take it seriously,” adds Anu. However, they believe there now has been a shift in attitude and people are slowly understanding the value and importance of preventive cure.
Since the products were relatively new in India, one challenging aspect was on boarding the right sales team. From ones who weren’t able to spell Genomepatri to understanding what the product does, the team has had a long haul in getting the right people.
“Everyone believes initially that it is an easy product or easy set of products to sell. Explaining and education is very important, and it this point in time we are best equipped to do that. The basics of how genetics affects behaviour, skills and even the mind needs to be explained,” adds Anu.
More than Genomepatri
“Any great business takes time to build, you need someone who can be persistent, can stay at it and actually solve the problem. I saw that in Anu, she has deep domain expertise and was passionate about the problem,” says Rajan Anandan, Investor at Mapmygenome.
Today at Mapmygenome there is so much more that they do with the genetic build and DNA, than simply creating the Genomepatri. Right from the beginning, the team knew they needed the right partners and the trust of the doctors with them. This made the team look at building a doctor base and the consumer side as well. “It is easy to get a doctor’s attention, because we are all interested in the space,” adds Anu.
Thus Mapmygenome, being both a B2C and B2B company, also has molecular diagnostics kits that specialise in tuberculosis and will be working on dengue as well. Anu adds that there is a division in the organisation that works on infectious diseases.
Citing an example of how that works, Anu says that supposing an individual goes to a doctor with a suspicion that he or she has TB, the doctors and diagnostic labs are able to give a 50–60 per cent possibility. “This isn’t very accurate, so our team is working towards making that diagnosis 99 per cent accurate,” says Anu.
The diagnostics wing of Mapmygenome is more B2B, where there is a need in the market for accurate and stronger diagnostic tests. The organisation uses genes to help bring in this accuracy.
“We always had the diagnostics aspects and they also are a part of our website, but the Genomepatri has been spoken more about as it focusses on prevention and is more consumer centric,” adds Anu.
Adding different panels
While Genomepatri is known as a personal report of an individual’s genetic makeup, Anu says there is more to it than just doing a genetic report. While an individual looks at their genetic makeup, they also need to look at their family and health history. This is in order to make a serious interpretation of what needs to be done to reduce the risk.
Initially, while the team would provide counselling along with the reports, they realised it wasn’t something the layman easily understood. In the past one year, the report also has a recommendations sheet, which helps people understand what the genetic report said and what they needed to do to reduce the risks. It also tells them what are different medical steps and preventive tests one can take.
The process is relatively simple. The consumer gives in a swab sample of their DNA (like a cheek swab), along with a consent form. Post which, the team works on the sample and sits with the consumer for a counselling session. After the counselling, they are given a list of recommendations and other steps.
With time, the Genomepatri has seen different additions, one being the recommendations report, and the other being dividing the product into 16 panels. The lite version has the basic eight panels, over this the patient chooses whether he or she wants to add more panels. “So cost of the basic lite report is at a certain price and the consumer pays Rs 2000 to get additional panels,” adds Anu.
The traction and market
Rajan adds that genetics is a large addressable market and is also very useful to the end consumer. “The first company to have the Indian genome mapped out can have all kinds of possibilities. It is facilitating towards saving millions of lives,” adds Rajan.
The team say that they started with a small base and so saw five times the growth. However, in FY 2014–2015, they doubled and this year they will see a growth that is close to three times more than last year. While the team refused to share the exact revenue details, Anu says they are now at a few crores of revenue. Mapmygenome has tie-ups with more than 38 hospitals across the country.
Genetic testing is fast growing not only in the global markets but even in India. Of these, newborn and prenatal genetic testing market is believed to touch a CAGR of 31.91 per cent. Some of the companies that are into genetic testing include the US-based 23andMe, Igenomix, which also has a subsidiary in India and Positive Bioscience among others.
“Healthtech and medtech today is where consumer Internet was at 2005. I think we are going to see many more true technology-driven companies in healthtech. There will be many more disruptive medical device technology in the space. This space is in fact going to be bigger than the consumer Internet space in the next 10–15 years,” says Rajan.
However, there still is a long way to go according to the Indian Journal of Human Genetics report, close to 90 per cent of the Indian medical colleges are yet to provide training and education in the space of genetics.
Mapmygenome Partners With Blockchain Startup Digital DNAtix
NEW YORK (GenomeWeb) – Indian consumer genomics company Mapmygenome is partnering with blockchain genetics startup Digital DNAtix to provide extra security and privacy for its direct-to-consumer genetic tests. The blockchain technology also will allow researchers to access anonymous data for their work, the companies said.
Digital DNAtix, of Ramat Gan, Israel, will provide Mapmygenome with a platform to offer its genome testing, analysis, and related personalized medicine services in a faster, more secure environment than previously available.
How Indian DNA Test Startup Mapmygenome Draws From Astrology.
In Hindu culture, birth charts hold special significance. These Vedic horoscopes, called “Janampatri,” lay out the positions of celestial bodies—like the sun, moon, and planets—at the time of a person’s birth so as to reveal information, purportedly, about that person’s life. People consult them to learn what the heavens have supposedly preordained about their marriage compatibility, health, and wealth.
Even though scientists dismiss the practice, when Anu Acharya founded Mapmygenome, a DNA testing startup in India, she decided to give the folk tradition a nod. Acharya, who is CEO of the Hyderabad-based company, markets home DNA testing kits under a name that cleverly alludes to Janampatri. They’re called “Genomepatri.”
“Genomics was not something that was naturally relatable to most consumers in India,” Acharya told an audience at Fortune’s Brainstorm Health conferencein San Diego, Calif. on Wednesday morning. “So we said what is the closest thing that people can relate to, and that was astrology.”
The analogy makes sense, as Fortune executive editor Adam Lashinsky pointed out on stage: “It’s a taxonomy for understanding life.”
“I’m not making a judgment on whether the Janampatri is scientifically right,” Acharya replied. “But it essentially gives you a guidance on whether you should marry somebody.”
Extending the astrological analogy, Acharya noted that people carrying genes that put offspring at high risk for certain heritable diseases might decide on the right mate based on their genetic profiles. The tests use a swab of saliva to determine a person’s genetic makeup.
Some genes are associated with higher incidences of certain diseases, like cancer or Parkinson’s. Women who have the BRCA1 and BRCA2 genetic mutations are, for instance, at higher risk of developing breast cancer.
On stage as well, Alejandra Campoverdi, a women’s health advocate and former White House aide under former President Barack Obama, said that she had recently taken a genetic test to determine if she might be a carrier of the BRCA mutation as several members of her family had been diagnosed with breast cancer over the years. Campoverdi learned that she is indeed a carrier, a finding that has persuaded her to eventually undergo a double mastectomy, a personal choice that matches the recommendations of her doctors.
Acharya believes that genetic testing will help pave the way for preventative health care. She formerly founded Ocimum Bio Solutions, another genetic testing company.
“I just got an offer from somebody who is an astrologer and is a VC who said that we should do a study of both of them together,” Acharya said.
ThinkGenetic Mapmygenome join hands to improve genetic services.
The US-based ThinkGenetic and Mapmygenome, a personal genomics company in Hyderabad, have joined hands to improve genetic services and diagnostics for providing better preventive healthcare.
Through this partnership, ThinkGenetic users from India will be able to connect more easily to the resources closer to them. Mapmygenome, which currently specialises in clinical genomics and molecular diagnostics, has teams providing genetic services all over India.